About Tangen Biosciences LLC
Tangen Biosciences LLC is a leading molecular diagnostic company that is revolutionizing the way we diagnose diseases. The company has developed fast assays for COVID-19, Respiratory Panel Bacterial Panel, and AMR Candida auris. With its cutting-edge technology and innovative approach to diagnostics, Tangen Biosciences LLC is changing the molecular diagnostic paradigm.
The COVID-19 pandemic has highlighted the importance of rapid and accurate diagnostic testing. Tangen Biosciences LLC's COVID-19 assay provides results in just 30 minutes, making it one of the fastest tests on the market. This test uses a simple sample collection method that can be performed by healthcare professionals or patients themselves.
In addition to its COVID-19 assay, Tangen Biosciences LLC also offers a Respiratory Panel Bacterial Panel that can detect multiple respiratory pathogens in a single test. This panel includes tests for common bacterial infections such as Streptococcus pneumoniae and Haemophilus influenzae as well as atypical bacteria like Mycoplasma pneumoniae and Legionella pneumophila.
Another area where Tangen Biosciences LLC excels is in detecting antimicrobial resistance (AMR). The company's AMR Candida auris assay can identify this dangerous fungus in just two hours, allowing healthcare providers to quickly isolate infected patients and prevent further spread of the disease.
Tangen Biosciences LLC's assays are based on its proprietary technology called "TangenDx". This technology uses loop-mediated isothermal amplification (LAMP) to amplify DNA sequences from patient samples without requiring expensive equipment or specialized training. The result is a highly sensitive and specific test that can be performed anywhere with minimal infrastructure requirements.
The company's commitment to innovation extends beyond its products. It also offers customized solutions for research institutions, hospitals, clinics, and public health agencies looking to develop their own LAMP-based assays. These solutions include training programs for laboratory personnel as well as technical support throughout the development process.
Tangen Biosciences LLC was founded by Drs. David Erickson and Brian Cunningham in 2014 with funding from National Institutes of Health (NIH) Small Business Innovation Research grants. Since then, it has grown rapidly thanks to partnerships with major pharmaceutical companies like Pfizer Inc., Merck & Co., Inc., Johnson & Johnson Services Inc., among others.
In conclusion, Tangen Biosciences LLC is an innovative molecular diagnostic company that offers fast assays for COVID-19, Respiratory Panel Bacterial Panel,and AMR Candida auris using its proprietary technology called "TangenDx". Its commitment to innovation extends beyond product development into customized solutions for research institutions,hospitals,and clinics lookingto develop their own LAMP-based assays.Thecompanyhasgrownrapidlysinceitsfoundingin2014andcontinuestobreaknewgroundinthe fieldofmoleculardiagnosticswithitscutting-edgetechnologyandinnovativeapproachto diagnostics.This makes it one ofthe most reliable companies when it comes tomolecular diagnosis testing services globally